JP2022543038A5 - - Google Patents

Info

Publication number
JP2022543038A5
JP2022543038A5 JP2022506401A JP2022506401A JP2022543038A5 JP 2022543038 A5 JP2022543038 A5 JP 2022543038A5 JP 2022506401 A JP2022506401 A JP 2022506401A JP 2022506401 A JP2022506401 A JP 2022506401A JP 2022543038 A5 JP2022543038 A5 JP 2022543038A5
Authority
JP
Japan
Prior art keywords
polymerosomes
group
antigen
poly
pharmaceutical product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022506401A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022543038A (ja
JP7676030B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/071809 external-priority patent/WO2021019102A2/en
Publication of JP2022543038A publication Critical patent/JP2022543038A/ja
Publication of JP2022543038A5 publication Critical patent/JP2022543038A5/ja
Application granted granted Critical
Publication of JP7676030B2 publication Critical patent/JP7676030B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022506401A 2019-08-01 2020-08-03 関連づけられた抗原を有するポリマーソームの集団を、関連づけられたアジュバントを有するポリマーソームの集団と一緒に投与することによって、免疫応答を誘発する方法、およびそれら２つのポリマーソーム集団を含む組成物 Active JP7676030B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP19189549 2019-08-01
EP19189549.9 2019-08-01
EP20171327.8 2020-04-24
EP20171327 2020-04-24
PCT/EP2020/071809 WO2021019102A2 (en) 2019-08-01 2020-08-03 A method of eliciting an immune response by administering a population of polymersomes having an associated antigen together with a population of polymersomes having an associated adjuvant as well as compositions comprising the two populations of polymersomes

Publications (3)

Publication Number Publication Date
JP2022543038A JP2022543038A (ja) 2022-10-07
JP2022543038A5 true JP2022543038A5 (enExample) 2024-02-20
JP7676030B2 JP7676030B2 (ja) 2025-05-14

Family

ID=72148072

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022506401A Active JP7676030B2 (ja) 2019-08-01 2020-08-03 関連づけられた抗原を有するポリマーソームの集団を、関連づけられたアジュバントを有するポリマーソームの集団と一緒に投与することによって、免疫応答を誘発する方法、およびそれら２つのポリマーソーム集団を含む組成物

Country Status (9)

Country Link
US (1) US20220273792A1 (enExample)
EP (1) EP4007597A2 (enExample)
JP (1) JP7676030B2 (enExample)
CN (1) CN114502191B (enExample)
AU (1) AU2020322107A1 (enExample)
BR (1) BR112022001185A2 (enExample)
CA (1) CA3143533A1 (enExample)
PH (1) PH12022550112A1 (enExample)
WO (1) WO2021019102A2 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104936579B (zh) * 2012-11-19 2020-02-07 新加坡科技研究局 用于引发对免疫原的免疫响应的方法
US20180128545A1 (en) 2016-11-08 2018-05-10 Berry Metal Company Modular furnace cooling wall
US12384811B2 (en) 2019-04-05 2025-08-12 Academia Sinica Sialidase-resistant saccharide and method of making and using the same
KR102657261B1 (ko) * 2020-04-03 2024-04-15 조선대학교산학협력단 Ｃｏｖｉｄ－１９ 진단을 위한 재조합 코로나－１９ 바이러스 스파이크 단백질의 생산 및 이의 용도
WO2021214339A2 (en) * 2020-04-24 2021-10-28 Acm Biolabs Pte Ltd Vaccine against human-pathogenic coronaviruses
TWI870591B (zh) 2020-05-08 2025-01-21 中央研究院 嵌合流感疫苗
JP2023550094A (ja) * 2020-11-12 2023-11-30 ティースキャン セラピューティクス インコーポレイテッド Ｓａｒｓ－ｃｏｖ－２免疫優性ペプチドの構築物及びその使用
JP2024500360A (ja) * 2020-12-11 2024-01-09 エイシーエム バイオラブズ プライベート リミテッド 関連づけられた抗原および関連づけられたアジュバントを有する２つのポリマーソーム集団を投与することによる、Ｔｈ１／Ｔｈ２免疫応答の調整方法
CN117597109A (zh) * 2021-02-02 2024-02-23 Acm 生物实验室私人有限公司 聚合物囊泡相关联的佐剂用于刺激免疫应答的单独使用
WO2022171182A1 (zh) * 2021-02-10 2022-08-18 斯微(上海)生物科技股份有限公司 一种治疗或者预防冠状病毒病突变株的疫苗试剂
WO2022180635A1 (en) * 2021-02-25 2022-09-01 Migvax Ltd. Oral compositions and use of same in vaccination
US20240181041A1 (en) * 2021-03-16 2024-06-06 The Wistar Institute Adenovirus SARS-CoV-2 Vaccine
US20220323569A1 (en) * 2021-03-30 2022-10-13 Qiang Chen Plant-produced vlps and ric vaccines
WO2022212505A1 (en) * 2021-03-30 2022-10-06 Arizona Board Of Regents On Behalf Of Arizona State University Optimal production of sars-cov-2 virus-like particles (vlps) produced in mammalian cells
BR112023005961A2 (pt) * 2021-04-12 2023-10-24 Academia Sinica Molécula de ácido nucleico modificada, vacina combinada, nanopartícula, nanocluster de mrna, método para prevenir ou tratar uma infecção por coronavírus, método para reforço de uma resposta imune adaptativa, peptídeo imunogênico e composição imunogênica
BR112023000666A2 (pt) * 2021-04-12 2023-10-24 Academia Sinica Imunógeno, composição imunogênica, método para induzir uma resposta imune contra um coronavírus 2 da síndrome respiratória aguda grave e uso da composição imunogênica
CN115337404A (zh) * 2021-05-12 2022-11-15 中国医学科学院基础医学研究所 细胞微颗粒在治疗呼吸道病毒性肺炎上的应用
WO2022251101A2 (en) * 2021-05-24 2022-12-01 nference, inc. Compositions and methods related to surge-associated sars-cov-2 mutants
WO2023004415A2 (en) * 2021-07-22 2023-01-26 University Of Miami Sars-cov-2 vaccine using bacterial spores expressing antigenic fragments
CN113633764B (zh) * 2021-09-02 2024-05-14 中国食品药品检定研究院 一种含佐剂的新冠dna疫苗
IT202100023816A1 (it) * 2021-09-16 2023-03-16 Takis S R L Anticorpo contro SARS-CoV-2 e suoi usi in campo medico.
TW202334429A (zh) 2021-10-01 2023-09-01 中央研究院 Sars-cov-2棘蛋白特異性抗體及其用途
WO2023060220A1 (en) * 2021-10-07 2023-04-13 BioVaxys Inc. Methods of immunization against coronavirus
CN114470186B (zh) * 2022-02-17 2023-10-20 唐颐控股(深圳)有限公司 一种可吸入式纳米新冠疫苗的制备方法
AU2024252371B2 (en) 2023-04-08 2026-02-12 Rock Biomedical Inc. Methods and compositions for dendritic cell targeting nano-delivery
US12318485B2 (en) 2023-04-08 2025-06-03 Rock Biomedical, Inc. Methods and compositions for targeted delivery by polymersomes
WO2024238734A2 (en) 2023-05-17 2024-11-21 Rock Biomedical Inc. Mgat1 deficient cells and uses thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5354934A (en) 1993-02-04 1994-10-11 Amgen Inc. Pulmonary administration of erythropoietin
JP2002514397A (ja) * 1998-05-14 2002-05-21 コーリー ファーマシューティカル ゲーエムベーハー ＣｐＧオリゴヌクレオチドを用いる造血調節の方法
US6835394B1 (en) * 1999-12-14 2004-12-28 The Trustees Of The University Of Pennsylvania Polymersomes and related encapsulating membranes
US20080181939A1 (en) * 1999-12-14 2008-07-31 Trustees Of The University Of Pennsylvania Polymersomes and related encapsulating membranes
EP2281033B1 (en) 2008-04-17 2014-10-15 Vin de Bona Trading Co Pte Post release modification of viral envelopes
US8323696B2 (en) 2008-08-29 2012-12-04 Ecole Polytechnique Federale De Lausanne Nanoparticles for immunotherapy
CN102460150B (zh) 2009-04-20 2015-05-20 新加坡科技研究局 囊泡系统及其用途
CN102917690B (zh) * 2010-03-19 2016-08-24 麻省理工学院 脂质囊泡组合物和使用方法
EP2601262A4 (en) 2010-08-05 2014-01-22 Agency Science Tech & Res VESIGN STRUCTURE WITH SEVERAL CHAMBERS AND METHOD FOR THEIR EDUCATION
EP4218808A3 (en) 2012-03-12 2023-08-09 Advanced BioAdjuvants, LLC Adjuvant and vaccine compositions
DK2906717T3 (en) 2012-10-11 2019-04-01 Vin De Bona Trading Company Pte Ltd PROCEDURE FOR PAINTING MICROVESICS
CN104936579B (zh) 2012-11-19 2020-02-07 新加坡科技研究局 用于引发对免疫原的免疫响应的方法
EP2898894A1 (en) 2014-01-27 2015-07-29 LTS LOHMANN Therapie-Systeme AG Nano-in-micro particles for intradermal delivery
WO2016055611A1 (en) * 2014-10-09 2016-04-14 Universität Basel Self-assembled nanostructures and methods of use thereof
US9636397B2 (en) 2015-03-24 2017-05-02 VaxLiant, LLC Adjuvant compositions and related methods
WO2019145475A2 (en) * 2018-01-25 2019-08-01 Acm Biolabs Pte Ltd Polymersomes comprising a soluble encapsulated antigen as well as methods of making and uses thereof
CN108969771B (zh) * 2018-08-07 2021-06-29 中国医学科学院生物医学工程研究所 甘露糖修饰的共载抗原和双免疫激动剂磷脂杂化聚合物囊泡及其制备方法与应用

Similar Documents

Publication Publication Date Title
JP2022543038A5 (enExample)
Hameed et al. Towards the future exploration of mucosal mRNA vaccines against emerging viral diseases; lessons from existing next-generation mucosal vaccine strategies
US10973909B1 (en) Coronavirus vaccine
Li et al. Enhanced intranasal delivery of mRNA vaccine by overcoming the nasal epithelial barrier via intra-and paracellular pathways
Rattanakiat et al. The assembly of a short linear natural cytosine-phosphate-guanine DNA into dendritic structures and its effect on immunostimulatory activity
JP2022539105A (ja) 治療に好適なｒｎａ製剤
CN105473158B (zh) 呼吸道合胞病毒(rsv)疫苗
CN115867654A (zh) Rna构建体及其用途
Zhang et al. A comparative study of the antigen‐specific immune response induced by co‐delivery of CpG ODN and antigen using fusion molecules or biodegradable microparticles
CN115297892A (zh) 抗新型冠状病毒感染的mRNA疫苗的组合物和方法
Neshat et al. Gene delivery for immunoengineering
Gupta et al. A review of the role of CpG oligodeoxynucleotides as toll-like receptor 9 agonists in prophylactic and therapeutic vaccine development in infectious diseases
JP2021512142A5 (enExample)
JP2023532290A5 (enExample)
ES2575395T3 (es) Composiciones para la transfección de células
Kabiri et al. Robust mucosal and systemic responses against HTLV-1 by delivery of multi-epitope vaccine in PLGA nanoparticles
TW201026323A (en) Immunostimulatory oligonucleotides
Simón-Vázquez et al. Polymeric nanostructure vaccines: applications and challenges
CN101835487A (zh) 制备和使用流感蛋白质的组合物和方法
JP2023549017A5 (enExample)
JP2009524584A (ja) ポリマー−生物製剤送達組成物を構築するための方法
JP2025500880A5 (enExample)
Brubaker et al. A cationic micelle complex improves CD8+ T cell responses in vaccination against unmodified protein antigen
JP2016517402A (ja) 自己組織化合成タンパク質（Ｓｅｌｆ−ＡｓｓｅｍｂｌｉｎｇＳｙｎｔｈｅｔｉｃＰｒｏｔｅｉｎｓ）
JP2024500360A5 (enExample)